Clarissa Damaso

Instituição:

Universidade Federal do Rio de Janeiro

Centro:

Centro de Ciências da Saúde

Unidade:

Instituto de Biofísica Carlos Chagas Filho

Departamento:

Programa de Biologia Molecular e Estrutural/Biof

ORCID:

https://orcid.org/0000-0001-6299-2816


Formação:

  • Universidade Federal do Rio de Janeiro

    | Pós-Doutorado | 1996 - 1997

  • Universidade Federal do Rio de Janeiro

    Ciências Biológicas (Biofísica) | Doutorado | 1990 - 1996

  • Universidade Federal do Rio de Janeiro

    Ciências Biológicas (Biofísica) | Mestrado | 1987 - 1990

  • Universidade Federal do Rio de Janeiro

    Ciências Biológicas | Graduação | 1982 - 1985
Laboratórios:
Nuvens de Palavras:
Artigos:

(93.22% artigos com DOI)

Titulo DOI Ano
Mpox outbreak in Rio de Janeiro, Brazil: A translational approach 10.1002/jmv.29621 2024
Genomic Characterization of the Historical Smallpox Vaccine Strain Wyeth Isolated from a 1971 Seed Vial 10.3390/v15010083 2023
Evaluation of SARS-CoV-2 ORF7a Deletions from COVID-19-Positive Individuals and Its Impact on Virus Spread in Cell Culture 10.3390/v15030801 2023
Co-circulation of vaccinia and monkeypox viruses in rural areas of Brazil: Importance of differential molecular diagnosis 10.1016/j.tmaid.2023.102578 2023
ICTV Virus Taxonomy Profile: Poxviridae 2023 10.1099/jgv.0.001849 2023
Phasing out monkeypox: mpox is the new name for an old disease 10.1016/j.lana.2022.100424 2023
In vitro susceptibility of eighteen clinical isolates of human monkeypox virus to tecovirimat 10.1590/0074-02760230056 2023
Gene duplication, gene loss, and recombination events with variola virus shaped the complex evolutionary path of historical American horsepox-based smallpox vaccines 10.1128/mbio.01887-23 2023
First reports of monkeypox and varicella-zoster virus coinfection in the global human monkeypox outbreak in 2022 10.1016/j.tmaid.2022.102510 2023
The 2022 monkeypox outbreak alert: Who is carrying the burden of emerging infectious disease outbreaks? 10.1016/j.lana.2022.100315 2022
Searching for the origin of the smallpox vaccine: Edward Jenner and his little-known horsepox hypothesis 10.1016/j.vaccine.2022.11.007 2022
Emerging Monkeypox virus and neuroinflammatory disorders 10.1016/j.ijregi.2022.08.015 2022
Unusual epidemiological presentation of the first reports of monkeypox in a low-income region of Brazil 10.1016/j.tmaid.2022.102466 2022
Genomic diversity of vaccinia virus strain Cantagalo isolated in southeastern Brazil during the early years of the outbreak, 1999-2006 10.1590/0074-02760200521 2021
Bioterrorismo: o ?Estado da Arte? da detecção de Agentes Patogênicos 2021
Early smallpox vaccine manufacturing in the United States: Introduction of the -animal vaccine- in 1870, establishment of -vaccine farms-, and the beginnings of the vaccine industry 10.1016/j.vaccine.2020.05.037 2020
Potencial do vírus da varíola como arma biológica no cenário mundial atual 2020
Investigations on the historical origin and evolution of the smallpox vaccine 10.47307/GMC.2020.128.s1.11 2020
Re-assembly of 19th-century smallpox vaccine genomes reveals the contemporaneous use of horsepox and horsepox-related viruses in the United States 10.1186/s13059-020-02202-0 2020
Amazonian Phlebovirus (Bunyaviridae) potentiates the infection of Leishmania (Leishmania) amazonensis: Role of the PKR/IFN1/IL-10 axis 10.1371/journal.pntd.0007500 2019
Validation of a real-time PCR assay for detection of swinepox virus 10.1007/s00705-019-04403-w 2019
Revisiting Jenner's mysteries, the role of the Beaugency lymph in the evolutionary path of ancient smallpox vaccines 10.1016/S1473-3099(17)30445-0 2018
Beyond the myths: novel findings for old paradigms in the history of the smallpox vaccine 10.1371/journal.ppat.1007082 2018
Development of standard methods for Zika virus propagation, titration, and purification 10.1016/j.jviromet.2017.04.011 2017
Autochthonous Transmission of East/Central/South African Genotype Chikungunya Virus, Brazil 10.3201/eid2310.161855 2017
An Early American Smallpox Vaccine Based on Horsepox 10.1056/NEJMc1707600 2017
Equination (inoculation of horsepox): An early alternative to vaccination (inoculation of cowpox) and the potential role of horsepox virus in the origin of the smallpox vaccine 10.1016/j.vaccine.2017.11.003 2017
One-step duplex polymerase chain reaction for the detection of swinepox and vaccinia viruses in skin lesions of swine with poxvirus-related disease 10.1016/j.jviromet.2015.03.010 2015
Genomic Analysis, Phenotype, and Virulence of the Historical Brazilian Smallpox Vaccine Strain IOC: Implications for the Origins and Evolutionary Relationships of Vaccinia Virus 10.1128/jvi.01833-15 2015
Are We There Yet? The Smallpox Research Agenda Using Variola Virus 10.1371/journal.ppat.1004108 2014
Presence of neutralizing antibodies to Orthopoxvirus in Capybaras (Hydrochoerus hydrochaeris) in Brazil 10.3855/jidc.5216 2014
Increased susceptibility of Cantagalo virus to the antiviral effect of ST-246® 10.1016/j.antiviral.2012.11.010 2013
Biological characterization and next-generation genome sequencing of the unclassified Cotia virus SPAn232 (Poxviridae) 10.1128/JVI.07162-11 2012
clpB, a class III heat-shock gene regulated by CtsR, is involved in thermotolerance and virulence of Enterococcus faecalis 10.1099/mic.0.041897-0 2011
Potent antiviral activity of brequinar against the emerging Cantagalo virus in cell culture 10.1016/j.ijantimicag.2011.07.002 2011
Animal Movement and Establishment of Vaccinia Virus Cantagalo Strain in Amazon Biome, Brazil 10.3201/eid1704.101581 2011
Swinepox Virus Outbreak, Brazil, 2011 10.3201/eid1710.110549 2011
In vitro activity of cidofovir against the emerging Cantagalo virus and the smallpox vaccine strain IOC. 10.1016/j.ijantimicag.2008.07.015 2009
Development of a 1-step cell-based assay for cost-effective screening of antiviral drugs for vaccinia virus 10.1016/j.diagmicrobio.2009.03.015 2009
Antiviral evaluation of N-amino-1,2,3-triazoles against Cantagalo virus replication in cell culture 10.1016/j.ejmech.2009.04.046 2009
Cidofovir Inhibits Genome Encapsidation and Affects Morphogenesis during the Replication of Vaccinia Virus 10.1128/jvi.01061-09 2009
Spread of Cantagalo Virus to Northern Brazil 10.3201/eid1507.081702 2009
Accuracy and repeatability of a micro plaque reduction neutralization test for vaccinia antibodies 10.1016/j.biologicals.2007.07.001 2008
When good vaccines go wild: Feral Orthopoxvirus in developing countries and beyond 10.3855/jidc.258 2008
A PCR-based assay for detection of emerging vaccinia-like viruses isolated in Brazil 10.1016/j.diagmicrobio.2006.07.012 2007
FK506, a secondary metabolite produced by Streptomyces, presents a novel antiviral activity against Orthopoxvirus infection in cell culture 10.1111/j.1365-2672.2006.02855.x 2006
Tabebuia avellanedae naphthoquinones: activity against methicillin-resistant staphylococcal strains, cytotoxic activity and in vivo dermal irritability analysis 10.1186/1476-0711-5-5 2006
An alternative genetic method to test essentiality of vaccinia virus early genes 10.1016/j.jviromet.2003.09.011 2004
Redistribution of Cyclophilin A to Viral Factories during Vaccinia Virus Infection and Its Incorporation into Mature Particles 10.1128/JVI.77.16.9052-9068.2003 2003
Protein Synthesis Inhibitory Activity in Culture Filtrates from New Strains of Streptomyces Isolated from Brazilian Tropical Soils 10.1046/j.1472-765X.2003.01363.x 2003
Accidental infection of laboratory worker with vaccinia virus 10.3201/eid0906.020732 2003
Azathioprine Inhibits Vaccinia Virus Replication in both BSC-40 and RAG Cell Lines Acting on Different Stages of Virus Cycle 10.1006/viro.2002.1534 2002
An Emergent Poxvirus from Humans and Cattle in Rio de Janeiro State: Cantagalo Virus, may Derive from Brazilian Smallpox Vaccine. 10.1006/viro.2000.0603 2000
Inhibition of vaccinia virus replication by cyclosporin A analogues correlates with their affinity for cellular cyclophilins. 10.1099/0022-1317-79-2-339 1998
Cyclosporin A inhibits vaccinia virus replication in vitro 10.1007/bf01310569 1994
Detection of RNA-Protein Complex in Vaccinia Virus Core in Vitro Transcription System 10.1099/0022-1317-73-5-1243 1992
Protein Synthesis in Vaccinia Virus-Infected Cells. I - Effect of Hypertonic Shock Recovery 10.1007/BF01317265 1992
Proteins Released from Vaccinia Cores are Probably not Involved in Protein Synthesis Inhibition in Vitro 1992
Vaccinia Core Transcription Prevents in Vitro Depolymerization of Polyribossomes in Rabbit Reticulocyte Lysate 1987
Eventos:

(0.00% eventos com DOI)

Titulo DOI Ano
DIVERSIDADE GENÉTICA E BIOLÓGICA DE VÍRUS CANTAGALO ISOLADOS NO BRASIL 2019
Comparative Genomic and Biological Analysis of Vaccinia Virus Strain Cantagalo Clinical Isolates. 2019
BIOLOGICAL AND GENOTYPIC CHARACTERIZATION OF CLINICAL ISOLATES OF CANTAGALO VIRUS 2018
BX-795 inhibits poxvirus replication 2018
Evaluation of humoral immunity and genomic studies of vaccine strains for improvement of smallpox preparedness in Brazil. 2018
Clinical and molecular diagnosis for biodefense against smallpox in Brazil. 2018
Effect of a TBK1 inhibitor, BX-795, on poxvirus replication 2017
SMALLPOX BIODEFENSE IN BRAZIL: HUMORAL IMMUNITY OF BRAZ MILITARIES AND GENOMIC OF VACCINE STRAINS 2017
AUTOCHTHONOUS TRANSMISSION OF EAST/CENTRAL/SOUTH AFRICAN GENOTYPE CHIKUNGUNYA VIRUS IN RIO DE JANEIRO, BRAZIL 2017
SMALLPOX BIODEFENSE IN BRAZIL: CLINICAL AND MOLECULAR DIAGNOSIS 2017
Evaluation of Humoral Immunity against Smallpox in Brazilian Army CBRN Troops 2016
Virulence and Genetic Diversity of the Historical Brazilian Smallpox Vaccine IOC 2016
Genotypic Diversity of Clinical Isolates of Cantagalo Virus 2016
Genetics and Biological Diversity of Vaccinia Virus Strain IOC 2016
Autophagy Inhibition by a Vaccinia Virus Virulence Factor 2016
Virulence, Immunogenicity and Genomic Analysis of the Brazilian Smallpox Vaccine Strain IOC 2015
Antibody Levels against Smallpox in Militaries of the Brazilian Army Involved in Biodefense 2015
Biological Characterization and Virulence of Clinical Specimens of Cantagalo Virus Isolated in Rondônia during Outbreaks of Poxvirus-Related Disease in Dairy Cows 2015
Autophagy during Poxvirus Infection 2015
Studies on the biological and genetic diversity of clinical specimens of Cantagalo virus isolated from dairy cattle in Rondônia 2014
Clonal selection and characterization of vaccinia virus strain IOC, the Brazilian smallpox vaccine 2014
Interactions of cotia virus with host cells 2014
Antiviral effect of lambda-2T on vaccinia virus replication 2013
Characterization of clones of the Brazilian smallpox vaccine strain 2013
Autophagy induction during cotia virus infection 2013
Differences in the the formation of actin tails in vaccinia virus and Cotia virus infected BSC-40 cells 2013
Biological differences of clinical specimens of cantagalo virus isolated during outbreaks in Rondônia 2013
Metagenomics analyses of a pustular wound colelcted from a dairy cow from Rondonia state, Brazil 2013
The involvment of virulence factors in autophagy during poxvirus infection 2013
Cotia Virus Span232: Proposed Member of a New Genus of the Poxviridae 2012
Biological and immunological characterization of the Brazilian smallpox vaccine 2012
Effect of natural and synthetic antiviral substances on vaccinia virus replication 2012
Analysis of virulence factors involved in several aspects of virus-cell interaction during poxvirus infection 2012
Induction of Autophagy during Cotia virus Infection 2012
OUTBREAK OF SWINEPOX VIRUS INFECTION IN PIG HERDS IN HOLAMBRA, SP, BRAZIL 2011
INHIBITION OF CANTAGALO VIRUS REPLICATION BY SULFATED GALACTAN ISOLATED FROM A RED ALGA: EFFECTS ON VIRUS ENTRY 2011
ANTIVIRAL EFFECT OF POLYSACCHARIDE LAMBDA-2T ISOLATED FROM MARINE ALGAE ON CANTAGALO VIRUS REPLICATION 2011
ANALISYS OF VACCINIA VIRUS VIRULENCE GENES IN VIRUS-CELL INTERACTION 2011
Virus Host-Cell Interactions during Cotia Virus Infection 2011
SPREAD OF CANTAGALO VIRUS INFECTION WITHIN THE AMAZON BIOME 2011
Increased susceptibility of Cantagalo virus to the antiviral effect of ST-246 2010
Studies on Cotia virus-host cell interactions 2010
Analysis of Virus-Host Cell Interactions during Cotia Virus Infection 2010
The Anti-Orthopoxvirus Drug ST-246 Inhibits Cantagalo Virus Replication with Increased Efficacy 2010
Studies on the mechanism of action of Cidofovir on the replicative cycle of vaccinia virus 2010
Cantagalo Virus Entry is Inhibited by Sulfated Galactan Isolated from Red Algae 2010
Antiviral Effect of Polysaccharides Isolated from Marine Algae on Cantagalo Virus Replication 2010
DNA replication of Cantagalo virus is the major target for the antiviral action of brequinar 2010
Differential sensitivity of vaccinia virus strains to ST-246: a severe inhibition of Cantagalo virus replication 2009
Identification of Cantagalo Virus During Outbreak of Pustular Disease Occuring in Dairy Cattle in the State of Tocantins 2009
Inhibition of Cantagalo Virus by Brequinar: stages affected in viral replication 2009
Inhibition of Cantagalo Virus Entry by Sulfated Galactan 2009
Interactions of Cotia Virus with Cellular Cytoskeleton 2009
Cidofovir, DNA Replication and Genome Encapsidation in Vaccinia Virus Cycle: New Insights into the Mechanism of Action 2009
A Cell-Based Assay for Fast, Cost-Effective Screening of Antiviral Drugs for Cytopathic Viruses 2009
Molecular Characterization of Cotia virus SPAn 232 (Poxviridae) 2008
Antiviral effect of brequinar on cantagalo virus replication 2008
Antiviral potential of sulfated-galactan on cantagalo virus replication 2008
Cantagalo virus replication is severely inhibites by ST-246: analysis of the F13L gene 2008
Effect of Cidofovir on the stages of vaccinia virus replicative cycle 2008
Screening of molecules isolated from Brazilian algae: evaluation of the antiviral effect on catagalo virus replication 2008
Polymorphismis analysis and sensitivity to ST-246 of vaccinia virus clinical samples 2008
Analysis of protein polymorphisms of Cantagalo and VACV-IOC viruses 2008
Mitochondrial apoptotic pathway triggered by vaccinia virus strain IOC and catagalo virus infection 2008
Studies of the anti-poxvirus activity of piperine 2008
Comparative Proteomic Analisys of Cantagalo and Vaccinia-IOC Viruses 2007
Study of The Antiviral Action of Cidofovir on The Replicative Cycle of Cantagalo and Vaccinia-IOC Viruses 2007
The complete sequence and analysis of the Interferon-gamma viroceptor gene (B8R) encoded by Cantagalo virus and Vaccinia virus strain-IOC 2007
Analysis of CTGV and VACV-IOC apoptosis induction during host infection and anti- apoptotic genes expression. 2007
Analysis of the Antiviral Activity of the Alkaloid-Amide Piperine on Vaccinia Virus (Strain WR) Replication 2007
The Antiviral Effect of ST-246 on Cantagalo Virus Replication 2007
Apoptosis induction in cells infected with Cantagalo virus and vaccinia virus strain IOC 2006
Comparative analysis of the interferon-gamma viroceptor gene (B8R) encoded by cantagalo virus and vaccinia virus strain-IOC 2006
Screening of napthoquinones and triazoles presenting antiviral activity on Cantagalo virus replication in cell culture 2006
Molecular Characterization and Studies on the replicative cycle of cotia virus (Poxviridade) 2006
Apoptosis induction in cells infected with Cantagalo virus and vaccinia virus strain IOC 2006
Antiviral activity of Cidofovir on the replicative cycle of Cantagalo and Vaccinia-IOC viruses 2006
Antiviral Effect of the alkaloid-amide Piperine on Vaccinia Virus (strain WR) Replication 2006
Apoptosis induction in cells infected with Cantagalo virus and vaccinia virus strain IOC. 2005
Molecular characterization and studies on the replicative cycle of Cotia virus (Poxviridae) 2005
Characterization of the antiviral effect of Cidofovir on Cantagalo virus and VV-IOC replication. 2005
Antiviral Effect of Piperine on Vaccinia Virus Replication 2005
DNA repair in UV-C irradiated vaccinia virus-infected cells 2004
Apoptosis induction in Cantagalo virus infected BSC-40 cells 2004
Cantagalo virus encodes a functional type I Interferon - binding protein 2004
Induction of Apoptosis in cantagalo Virus-Infected BSC-40 cells 2004
Characterization of the B18R Gene: A Functional Type I Interferon- Binding Protein from Cantagalo Virus and VV-IOC 2004
Acriflavine Inhibits Vaccinia Virus Replication in Cell Culture 2004
Antiviral Effect of Cidofovir on the Replication of Cantagalo Virus and the Vaccine Strain VV-IOC 2004
Antiviral Effect of Zeatin on the Replication of Vaccinia Virus 2004
Replication of vaccinia virus in cells that do not express the cellular PPIase Cyclophilin A 2003
Seroepidemiological survey for vaccinia antibodies in staff members of Bio-Manguinhos/FIOCRUZ 2003
Involvement of the Cellular PPIase Cyclophilin A in Vaccinia Virus Replicative Cycle 2002
Inhibition of Vaccinia Virus (VV) Replication by FK-506 2002
Azathioprine Inhibits Vaccinia Virus Replication in Both BSC-40 and RAG Cell Lines Acting on Different Stages of Virus Cycle 2002
Analysis of the vaccinia virus F11L gene Essentiality 2002
Inhibition of Vaccinia Virus Replication in BSC-40 Cells by the Immunosuppressant Brequinar 2002
Accidental Infection of Laboratory Worker with Vaccinia Virus (VV) 2002
Analysis of the vaccinia virus F11L gene Essentiality 2002
Characterization of SPI-2 gene from cantagalo Virus 2002
Inhibition of Vaccinia Virus (VV) Replication by FK-506 2002
Involvement of the Cellular PPIase Cyclophilin A in Vaccinia Virus Replicative Cycle 2002
Azathioprine Inhibits Vaccinia Virus Replication in Both BSC-40 and RAG Cells 2002
Standardization of a micro PRNT for vaccinia antibodies 2002
Envolvimento de CypA no Ciclo Replicativo do Vírus Vaccinia 2002
TThe Inhibition of Cell Protein Sinthesys by Culture Filtrates of New Strains of Streptomyces Isolated from Tropical Soils 2002
Inibição da Replicação do Vírus Vaccinia pelo Imunossupressor FK-506 2002
Inhibition of vaccinia virus replication in BSC-40 cells by the immunosuppressant Brequinar 2001
Involvement of cyclophilin A In vaccinia virus replicative cycle 2001
Azathioprine inhibits vaccinia virus replication in both BSC-40 and RAG cell lines acting on different stages of virus cycle. 2000
Cantagalo Virus: A Vaccinia Virus from Cattle and Milkers Isolated during a Recent Outbreak in Rio de Janeiro State, Brazil. 2000
Azathioprine inhibits vaccinia virus replication in both BSC-40 and RAG cell lines acting on different stages of virus cycle 2000
Studies on the interaction vaccinia virus-cyclophilin A and the effect of cyclosporin A on transcription in vitro 2000
Inhibition of Vaccinia Virus (VV) Replication by the Culture Filtrate of a new Species of Streptomyces 2000
The Effect of the Immunosuppressant Azathioprine on Vaccinia Virus Production in Cell Culture 1999
Antiviral Activity of Stevastelins A and B on Vaccinia Virus (VV) Replication 1999
Inhibition of Vaccinia Virus Replication by the Immunosuppressant FK-506 1999
The Yeast Two-Hybrid System as a Tool to Identify Interactions between Virus Proteins and Virus-Host Proteins 1998
Antiviral Activity of the Immunosuppressant FK-506 in Vaccinia Virus-Infected Cells 1998
Inhibition of Vaccinia Virus Replication by Cyclosporin A Analogs: Correlation with the Affinity for Cellular Cyclophilins 1996
Characterization of Cyclosporin A Antiviral Effect: Inhibition of the Early Stage of Vaccinia Virus (VV) Life Cycle 1996
Antiviral Effect of Ciclosporin A Analogs on Vaccinia Virus Replication Correlates with the Affinity for Cellular Cyclophilins 1996
Inhibitory Effect of Ciclosporin a (CSA) on Vaccinia virus (VV) Replication : Possible Involvement of CSA-Binding Proteins 1995
Ciclosporin A (CSA) and CSA Binding Proteins in Vaccinia Virus (VV) Infected Cells. 1994
Effect of Cyclosporin A on Vaccinia Virus in Vitro 1991
RNA-Protein Complex during Vaccinia Cores in Vitro Transcription 1991
Identificação de Complexo RNA-Proteína na Transcrição in Vitro do Virus Vaccinia 1991
A Inibição in Vitro da Sintese de Proteínas pelo Virus Vaccinia Ocorre Somente na Ausência de Transcrição Viral 1991
Síntese de Proteínas em Células Infectadas pelo Vírus Vaccínia 1991
In vitro Synthesized Vaccinia Virus (VV) mRNAs are Associated with Viral Core Proteins 1990
Protein Synthesis In Mammalian Cells Infected With Vaccinia Virus (VV) 1990
Protein Synthesis Inhibition in Mammalian Cells Infected with Vaccinia Virus 1990
In Vitro Synthesized Vaccinia Virus (VV) mRNA are Associated with Viral Core Proteins 1990
Estudo in vitro da Inibicao da Traducao pelo Virus Vaccinia 1989
Protein Synthesis Inhibition in Mammalian Cells Infected with Vaccinia Virus 1989
Inibicao da Sintese de Proteina de Celulas CV-1 pelo Virus Vaccinia 1989
Studies on the Inhibition of Protein Synthesis by Vaccinia Virus 1988
PPurificação de Metionina 35S por Cromatografia Liquida de Alta Pressão (HPLC) 1988
In vitro Inhibition of Protein Synthesis by Vaccinia Cores 1986
In vitro Inhibition of Protein Synthesis Induces by Vaccinia Virus is Restored by Ribonucleoside Triphosphates 1986
Initiation of protein synthesis in rabbit reticulocyte lysate in the presence of vaccinia cores. 1986
In Vitro Studies on the Inhibition of Protein Synthesis by Vaccinia Virus 1986
Publicações:
Minha Rede: